Agilent Technologies (A) fundamentals: P/E, valuation, undervalued?
Agilent Technologies · Health Care · ref. ETF XLV · price $157.69
In short — Agilent Technologies trades at 30.6× earnings (P/E), 23.4× forward, with a net margin of 19.6 % and revenue growth of +10 %. Read: Cheap for the growth (P/E 23 for ~60% growth (PEG 0.4)).
Is Agilent Technologies stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$157.69+26.2% over range
Aug 28, 25low $110.24 · high $159Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
82% recommend buying · 11 analysts
Valuation : Cheap for the growth — P/E 23 for ~60% growth (PEG 0.4)
Valuation
30.6
P/E (price/earnings)
23.4
Forward P/E
0.51
PEG
6.6
Price/book (P/B)
$44.5B
Market cap
5.16
EPS
Profitability & growth
19.6 %
Net margin
+10 %
Revenue growth
+60 %
Earnings growth
$3.5B
Total debt
Agilent Technologies income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $6.8B | $1.3B | 18.3 % |
| 2023 | $6.8B | $1.2B | 18.1 % |
| 2024 | $6.5B | $1.3B | 19.8 % |
| 2025 | $6.9B | $1.3B | 18.8 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Agilent Technologies's P/E and is the stock undervalued? What's a good P/E?
Agilent Technologies's P/E is 30.6 (forward 23.4). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is Agilent Technologies profitable?
Agilent Technologies has a net margin of 19.6 % (EPS 5.16). The company is profitable.
Is A stock expensive?
Our read: "Cheap for the growth" — P/E 23 for ~60% growth (PEG 0.4). Cross-check with growth and sector.
💬 A question about Agilent Technologies? The JPI assistant answers using our backtest data.
Keep exploring Agilent Technologies